ONCIMMUNE HOLDINGS PLC – Trademark Portfolio

Entity Type: 11

ONCIMMUNE HOLDINGS PLC holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ONCIMMUNE. The owner is based in NOTTINGHAM.

1 THANE ROAD

MEDICITY - D6 BUILDING

NOTTINGHAM NG906BH , GB

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ONCIMMUNE
ONCIMMUNE
Registered 2008

Trademark Classifications

ONCIMMUNE HOLDINGS PLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does ONCIMMUNE HOLDINGS PLC have?

ONCIMMUNE HOLDINGS PLC has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does ONCIMMUNE HOLDINGS PLC file in?

ONCIMMUNE HOLDINGS PLC files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are ONCIMMUNE HOLDINGS PLC's most well-known trademarks?

ONCIMMUNE HOLDINGS PLC's registered trademark portfolio includes well-known marks such as ONCIMMUNE. These are among 1 currently registered trademark in the portfolio.

What is ONCIMMUNE HOLDINGS PLC's trademark registration success rate?

ONCIMMUNE HOLDINGS PLC has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.